🔗 Visit the ClinicalTrials.gov page for NCT00228189
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Dendritic cell immunotherapy: mapping the way. | Nat Med | 2004 | 4.28 |
| 2 | Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice. | J Clin Invest | 2011 | 1.91 |
| 3 | Immunomonitoring tumor-specific T cells in delayed-type hypersensitivity skin biopsies after dendritic cell vaccination correlates with clinical outcome. | J Clin Oncol | 2005 | 1.48 |
| 4 | Dendritic cell vaccines in melanoma: from promise to proof? | Crit Rev Oncol Hematol | 2008 | 1.31 |
| 5 | Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. | Anticancer Res | 2010 | 0.96 |
| 6 | Antigen-specific vaccines for cancer treatment. | Hum Vaccin Immunother | 2014 | 0.89 |